首页 » SNK-6 Cell Line细胞株-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心

SNK-6 Cell Line细胞株-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心

  • 价  格:¥19300
  • 货  号:SNK-6 Cell Line
  • 产  地:北京
点击询问我要采购
 竭诚为您服务!
BioVector NTCC典型培养物保藏中心
联系人:Dr.Xu, Biovector NTCC Inc.

电话:400-800-2947 工作QQ:1843439339 (微信同号)

邮件:Biovector@163.com

手机:18901268599

地址:北京

已注册
 

SNK-6 Cell Line


Name: SNK-6

   Tissue: extranodal, blood_bone_marrow, haematopoietic_and_lymphoid_tissue

   Disease: lymphoma, leukaemia, lymphoid_neoplasm





Studies on nasal T/natural killer (NK)–cell
lymphoma have been hampered by its tendency to cause necrosis. Thus, the
establishment of cell lines of this neoplasm would seem to be valuable. This
study attempted to establish cell lines from primary lesions of this tumor, and
successfully obtained 2 novel Epstein-Barr virus (EBV)–positive cell lines,
SNK-6 and SNT-8, by means of high-dose recombinant interleukin 2. Flow
cytometry showed that SNK-6 had an NK-cell phenotype, CD3
CD4CD8CD19CD56+T-cell receptor (TCR) α/βTCR γ/δ, whereas SNT-8 was CD3+CD4CD8CD19CD56+TCR α/βTCR γ/δ+. These were consistent with immunophenotypes of their original tumors,
and the cell lines had monoclonal EBV clones identical to ones in their
original tumors. Thus, the cell lines developed from cells forming the primary
lesions. Genotypic analysis showed that SNK-6 had unrearranged TCR and
immunoglobulin heavy-chain genes, supporting the conclusion that SNK-6 was of
NK-cell lineage. On the other hand, SNT-8 had rearranged TCR β-, γ-, and
δ-chain genes, and together with its phenotype, SNT-8 proved to be a γδ T-cell
line. This is the first report of the establishment of cell lines from primary
lesions of nasal T/NK cell lymphomas, and the results demonstrated that there
are at least 2 lineages, NK- and γδ T-cell, in this neoplasm. Moreover, it has
been suggested that nasal T/NK cell lymphomas of these lineages may belong to
the same clinicopathologic entity because both types of cases shared common
clinical and histopathologic features.





Complete Growth Medium: 90%RPMI 1640+10%FBS+100 U/ml penicillin G
sodium (option); 100 µg/ml streptomycin sulfate (option);



Application: Cells and cancer research



BioVector NTCC Inc.

您正在向 biovector.net  发送关于产品 SNK-6 Cell Line细胞株-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心 的询问

点击“立即发送”后,我们将在1个工作日内与您取得联系。